Therapeutic agent for a lung disease and/or method for screening for the same
US11279931B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 23, 2019 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Dec 23, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a therapeutic and/or prophylactic agent for a lung disease and a method for screening for the therapeutic and/or prophylactic agent. Provided are a therapeutic and/or prophylactic agent for a lung disease comprising an Arid5A inhibitor as an active ingredient and a method for screening for the therapeutic and/or prophylactic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.